Patent · US Active

Compounds and conjugates thereof

US11446292B2 · kind B2 · utility

0Cited by
10References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2021
Grant dateSep 20, 2022
Priority date
Expiry dateJun 15, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A conjugate comprising the following topoisomerase inhibitor derivative (A*): with a linker for connecting to a Ligand Unit, wherein the linker is attached in a cleavable manner to the amino residue. The Ligand Unit is preferably an antibody. Also provided is A* with the linking unit attached, and intermediates for their synthesis, as well as the released warhead.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.